カテゴリー： QYResearch, 世界

世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年

【英語タイトル】Global Polycystic Ovary Syndrome (PCOS) Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X13285）・商品コード：DATA909X13285
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬に、用途別には、病院、クリニックにセグメント区分し、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要
・多嚢胞性卵巣症候群（PCOS）治療薬の製造コスト構成分析
・多嚢胞性卵巣症候群（PCOS）治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・多嚢胞性卵巣症候群（PCOS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（種類別）
（経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬）
・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（用途別）
（病院、クリニック）
・多嚢胞性卵巣症候群（PCOS）治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Sanofi、Novartis AG、Teva Pharmaceutical Industries Limited、Addex Therapeutics Ltd.、BIOCAD、Merck KGaA、AstraZeneca plc.、Bristol Myers Squibb Co.、Ferring Pharmaceuticals, Inc.、Crinetics Pharmaceuticals, Inc.、）
・多嚢胞性卵巣症候群（PCOS）治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Polycystic Ovary Syndrome (PCOS) Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Polycystic Ovary Syndrome (PCOS) Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Sanofi
Novartis AG
Teva Pharmaceutical Industries Limited
Addex Therapeutics Ltd.
BIOCAD
Merck KGaA
AstraZeneca plc.
Bristol Myers Squibb Co.
Ferring Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oral Contraceptives
Antiandrogens
Insulin-sensitizing Agent
Antidepressant
Anti-obesity

Segment by Application
Hospital
Clinic

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Polycystic Ovary Syndrome (PCOS) Drugs
1.1 Definition of Polycystic Ovary Syndrome (PCOS) Drugs
1.2 Polycystic Ovary Syndrome (PCOS) Drugs Segment by Type
1.2.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Oral Contraceptives
1.2.3 Antiandrogens
1.2.4 Insulin-sensitizing Agent
1.2.5 Antidepressant
1.2.6 Anti-obesity
1.3 Polycystic Ovary Syndrome (PCOS) Drugs Segment by Applications
1.3.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Polycystic Ovary Syndrome (PCOS) Drugs Overall Market
1.4.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue (2014-2025)
1.4.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Production (2014-2025)
1.4.3 North America Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)
1.4.4 Europe Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)
1.4.5 China Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)
1.4.6 Japan Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)
1.4.8 India Polycystic Ovary Syndrome (PCOS) Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Polycystic Ovary Syndrome (PCOS) Drugs
2.3 Manufacturing Process Analysis of Polycystic Ovary Syndrome (PCOS) Drugs
2.4 Industry Chain Structure of Polycystic Ovary Syndrome (PCOS) Drugs

3 Development and Manufacturing Plants Analysis of Polycystic Ovary Syndrome (PCOS) Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Polycystic Ovary Syndrome (PCOS) Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Polycystic Ovary Syndrome (PCOS) Drugs Production and Capacity Analysis
4.2 Polycystic Ovary Syndrome (PCOS) Drugs Revenue Analysis
4.3 Polycystic Ovary Syndrome (PCOS) Drugs Price Analysis
4.4 Market Concentration Degree

5 Polycystic Ovary Syndrome (PCOS) Drugs Regional Market Analysis
5.1 Polycystic Ovary Syndrome (PCOS) Drugs Production by Regions
5.1.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production by Regions
5.1.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Regions
5.2 Polycystic Ovary Syndrome (PCOS) Drugs Consumption by Regions
5.3 North America Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.3.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Production
5.3.2 North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Polycystic Ovary Syndrome (PCOS) Drugs Import and Export
5.4 Europe Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.4.1 Europe Polycystic Ovary Syndrome (PCOS) Drugs Production
5.4.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Polycystic Ovary Syndrome (PCOS) Drugs Import and Export
5.5 China Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.5.1 China Polycystic Ovary Syndrome (PCOS) Drugs Production
5.5.2 China Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Polycystic Ovary Syndrome (PCOS) Drugs Import and Export
5.6 Japan Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.6.1 Japan Polycystic Ovary Syndrome (PCOS) Drugs Production
5.6.2 Japan Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Polycystic Ovary Syndrome (PCOS) Drugs Import and Export
5.7 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.7.1 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Production
5.7.2 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Import and Export
5.8 India Polycystic Ovary Syndrome (PCOS) Drugs Market Analysis
5.8.1 India Polycystic Ovary Syndrome (PCOS) Drugs Production
5.8.2 India Polycystic Ovary Syndrome (PCOS) Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Polycystic Ovary Syndrome (PCOS) Drugs Import and Export

6 Polycystic Ovary Syndrome (PCOS) Drugs Segment Market Analysis (by Type)
6.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Production by Type
6.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Type
6.3 Polycystic Ovary Syndrome (PCOS) Drugs Price by Type

7 Polycystic Ovary Syndrome (PCOS) Drugs Segment Market Analysis (by Application)
7.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption by Application
7.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Market Share by Application (2014-2019)

8 Polycystic Ovary Syndrome (PCOS) Drugs Major Manufacturers Analysis
8.1 Sanofi
8.1.1 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.1.2 Sanofi Product Introduction, Application and Specification
8.1.3 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis AG
8.2.1 Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.2.2 Novartis AG Product Introduction, Application and Specification
8.2.3 Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Teva Pharmaceutical Industries Limited
8.3.1 Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.3.2 Teva Pharmaceutical Industries Limited Product Introduction, Application and Specification
8.3.3 Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Addex Therapeutics Ltd.
8.4.1 Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.4.2 Addex Therapeutics Ltd. Product Introduction, Application and Specification
8.4.3 Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 BIOCAD
8.5.1 BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.5.2 BIOCAD Product Introduction, Application and Specification
8.5.3 BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Merck KGaA
8.6.1 Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.6.2 Merck KGaA Product Introduction, Application and Specification
8.6.3 Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 AstraZeneca plc.
8.7.1 AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.7.2 AstraZeneca plc. Product Introduction, Application and Specification
8.7.3 AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Bristol Myers Squibb Co.
8.8.1 Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.8.2 Bristol Myers Squibb Co. Product Introduction, Application and Specification
8.8.3 Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Ferring Pharmaceuticals, Inc.
8.9.1 Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.9.2 Ferring Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.9.3 Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Crinetics Pharmaceuticals, Inc.
8.10.1 Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
8.10.2 Crinetics Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.10.3 Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Polycystic Ovary Syndrome (PCOS) Drugs Market
9.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Trend Analysis
9.1.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Polycystic Ovary Syndrome (PCOS) Drugs Regional Market Trend
9.2.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.2.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.2.3 China Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.2.4 Japan Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.2.5 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.2.6 India Polycystic Ovary Syndrome (PCOS) Drugs Forecast 2019-2025
9.3 Polycystic Ovary Syndrome (PCOS) Drugs Market Trend (Product Type)
9.4 Polycystic Ovary Syndrome (PCOS) Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Polycystic Ovary Syndrome (PCOS) Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Polycystic Ovary Syndrome (PCOS) Drugs
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share by Types in 2018
Figure Oral Contraceptives Product Picture
Figure Antiandrogens Product Picture
Figure Insulin-sensitizing Agent Product Picture
Figure Antidepressant Product Picture
Figure Anti-obesity Product Picture
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Million USD) (2014-2025)
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs) (2014-2025)
Figure North America Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Figure Europe Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Figure China Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Figure India Polycystic Ovary Syndrome (PCOS) Drugs Market Size (Million USD) (2014-2025)
Table Polycystic Ovary Syndrome (PCOS) Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Polycystic Ovary Syndrome (PCOS) Drugs in 2018
Figure Manufacturing Process Analysis of Polycystic Ovary Syndrome (PCOS) Drugs
Figure Industry Chain Structure of Polycystic Ovary Syndrome (PCOS) Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Manufacturing Plants Distribution
Table Polycystic Ovary Syndrome (PCOS) Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Polycystic Ovary Syndrome (PCOS) Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Polycystic Ovary Syndrome (PCOS) Drugs Production Share by Manufacturers in 2018
Table Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Polycystic Ovary Syndrome (PCOS) Drugs Revenue Share by Manufacturers in 2018
Table Polycystic Ovary Syndrome (PCOS) Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share by Regions 2014-2019
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share by Regions in 2018
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Regions 2014-2019
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Regions in 2018
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Polycystic Ovary Syndrome (PCOS) Drugs Consumption Market Share by Regions 2014-2019
Figure North America Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure China Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure India Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Polycystic Ovary Syndrome (PCOS) Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Polycystic Ovary Syndrome (PCOS) Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Polycystic Ovary Syndrome (PCOS) Drugs Market Share by Application (2014-2019)
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Sites and Area Served
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Product Introduction, Application and Specification
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate (2014-2019)
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Production Market Share (2014-2019)
Figure Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share (2014-2019)
Table Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Main Business and Markets Served
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Polycystic Ovary Syndrome (PCOS) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Polycystic Ovary Syndrome (PCOS) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Polycystic Ovary Syndrome (PCOS) Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Polycystic Ovary Syndrome (PCOS) Drugs by Application (2019-2025)
Table Polycystic Ovary Syndrome (PCOS) Drugs Distributors List
Table Polycystic Ovary Syndrome (PCOS) Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Sanofi、Novartis AG、Teva Pharmaceutical Industries Limited、Addex Therapeutics Ltd.、BIOCAD、Merck KGaA、AstraZeneca plc.、Bristol Myers Squibb Co.、Ferring Pharmaceuticals, Inc.、Crinetics Pharmaceuticals, Inc.、

★調査レポート[世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年] (コード：DATA909X13285)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 多嚢胞性卵巣症候群（PCOS）治療法の世界市場：規模・現状・予測2019-2025
    DATA909X18843 / QYResearch / 2019年11月25日 / ※当調査レポートでは、多嚢胞性卵巣症候群（PCOS）治療法の世界市場について調査・分析し、多嚢胞性卵巣症候群（PCOS）治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、排卵誘発剤、顔面発毛抑制剤、インスリン感作剤）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多嚢胞性卵巣症候群（PCOS）治療法市場動向 ・主要企業別マーケットシェア ・多嚢胞性卵巣症候群（PCOS）治療法の種類別市場規模2014-2019 （経口避妊薬、排卵誘発剤、顔面発毛抑制剤、インスリン感作剤） ・多嚢胞性卵巣症候群（PCOS）治療法の用途別市場規模2014-2019 （病院、診療所、その他） ・多嚢胞性卵巣症候群（PCOS）治療法の北米市場：主要企業・種類別/用途別市場規模 ・多嚢胞性卵巣症候群（PCOS）治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. In 2018, the global Polycystic Ovarian Syndrome (PCOS) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Polycystic Ovarian Syndrome (PCOS) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polycystic Ovarian Syndrome (PCOS) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America....
  • 世界の骨髄異形成症候群（MDS）治療薬市場 2019年
    DATA909X11785 / QYResearch / 2019年11月20日 / ※本調査レポートは、骨髄異形成症候群（MDS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他に、用途別には、入院患者、外来患者にセグメント区分し、骨髄異形成症候群（MDS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・骨髄異形成症候群（MDS）治療薬の世界市場概要 ・骨髄異形成症候群（MDS）治療薬の製造コスト構成分析 ・骨髄異形成症候群（MDS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・骨髄異形成症候群（MDS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・骨髄異形成症候群（MDS）治療薬のセグメント分析（種類別） （アザシチジン、レナリドマイド、デシタビン、デフェラシロクス、その他）...The global Myelodysplastic Syndrome (MDS) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Myelodysplastic Syndrome (MDS) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Myelodysplastic Syndrome (MDS) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Myelodysplastic Syndrome (MDS) Therapeutics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の急性呼吸窮迫症候群(ARDS)治療薬市場 2019年
    DATA909X02949 / QYResearch / 2019年11月15日 / ※本調査レポートは、急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他に、用途別には、入院患者、外来患者にセグメント区分し、急性呼吸窮迫症候群(ARDS)治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要 ・急性呼吸窮迫症候群(ARDS)治療薬の製造コスト構成分析 ・急性呼吸窮迫症候群(ARDS)治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・急性呼吸窮迫症候群(ARDS)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・急性呼吸窮迫症候群(ARDS)治療薬のセグメント分析（種類別） （メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他）...The global Acute Respiratory Distress Syndrome Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Respiratory Distress Syndrome Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Respiratory Distress Syndrome Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Acute Respiratory Distress Syndrome Therapeutics in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の多発性硬化症（MS）治療薬市場 2019年
    DATA909X11757 / QYResearch / 2019年11月20日 / ※本調査レポートは、多発性硬化症（MS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、コパキソン（酢酸グラチラマー、共重合体1）、ノバントロン（ミトキサントロン）、ギレニア（フィンゴリモド、Fty720）、オーバジオ（テリフルノミド）、テクフィデラ（フマル酸ジメチル）、フィラテグラス（Sb683699、T-0047）、シポニモド（Baf312）、その他に、用途別には、RRMS、SPMS、PPMS、PRMSにセグメント区分し、多発性硬化症（MS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多発性硬化症（MS）治療薬の世界市場概要 ・多発性硬化症（MS）治療薬の製造コスト構成分析 ・多発性硬化症（MS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多発性硬化症（MS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多発性硬化症（MS）治療薬のセグメント分析（種類別） （コパキソン（酢酸グラチラマー、共重合体1）、ノバントロン（ミトキサントロン）、ギレニア（フィンゴリモド、Fty720）、オーバジオ（テリフルノミド）、テクフィデラ（フマル酸ジメチル）、フィラテグラス（Sb683699、T-0047）、シポニモド（Baf312）、その他）...The global Multiple Sclerosis (MS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Multiple Sclerosis (MS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Multiple Sclerosis (MS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Multiple Sclerosis (MS) Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の急性心不全(AHF)治療薬市場 2019年
    DATA909X02947 / QYResearch / 2019年11月15日 / ※本調査レポートは、急性心不全(AHF)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他に、用途別には、病院、クリニック、ホームケアにセグメント区分し、急性心不全(AHF)治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・急性心不全(AHF)治療薬の世界市場概要 ・急性心不全(AHF)治療薬の製造コスト構成分析 ・急性心不全(AHF)治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・急性心不全(AHF)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・急性心不全(AHF)治療薬のセグメント分析（種類別） （β遮断薬、カルシウム拮抗薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）...The global Acute Heart Failure (AHF) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Heart Failure (AHF) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Heart Failure (AHF) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Acute Heart Failure (AHF) Therapeutics in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の呼吸器合胞体ウイルス（RSV）治療薬市場 2019年
    DATA909X14332 / QYResearch / 2019年11月20日 / ※本調査レポートは、呼吸器合胞体ウイルス（RSV）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、パリビズマブ、リバビリン、その他に、用途別には、病院薬局、ドラッグストア、小売薬局、その他にセグメント区分し、呼吸器合胞体ウイルス（RSV）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・呼吸器合胞体ウイルス（RSV）治療薬の世界市場概要 ・呼吸器合胞体ウイルス（RSV）治療薬の製造コスト構成分析 ・呼吸器合胞体ウイルス（RSV）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・呼吸器合胞体ウイルス（RSV）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・呼吸器合胞体ウイルス（RSV）治療薬のセグメント分析（種類別） （パリビズマブ、リバビリン、その他）...The global Respiratory Syncytial Virus (RSV) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Respiratory Syncytial Virus (RSV) Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Respiratory Syncytial Virus (RSV) Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Respiratory Syncytial Virus (RSV) Therapeutics in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の肺動脈高血圧症（PAH）治療薬市場 2019年
    DATA909X13888 / QYResearch / 2019年11月20日 / ※本調査レポートは、肺動脈高血圧症（PAH）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エンドセリン受容体拮抗薬（ERA）、プロスタサイクリンおよびプロスタサイクリンアナログ、ホスホジエステラーゼ5（PDE-5）、可溶性グアニル酸シクラーゼ（SGC）刺激剤に、用途別には、二次性肺高血圧症（SPH）、原発性肺高血圧症（PPH）にセグメント区分し、肺動脈高血圧症（PAH）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・肺動脈高血圧症（PAH）治療薬の世界市場概要 ・肺動脈高血圧症（PAH）治療薬の製造コスト構成分析 ・肺動脈高血圧症（PAH）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・肺動脈高血圧症（PAH）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・肺動脈高血圧症（PAH）治療薬のセグメント分析（種類別） （エンドセリン受容体拮抗薬（ERA）、プロスタサイクリンおよびプロスタサイクリンアナログ、ホスホジエステラーゼ5（PDE-5）、可溶性グアニル酸シクラーゼ（SGC）刺激剤）...The global Pulmonary Arterial Hypertension (PAH) Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pulmonary Arterial Hypertension (PAH) Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pulmonary Arterial Hypertension (PAH) Medicine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pulmonary Arterial Hypertension (PAH) Medicine in North America, Europe, China, Japan, Southeast Asia and...
  • 多嚢胞性卵巣症候群治療の世界市場：規模・現状・予測2019-2025
    DATA909X18844 / QYResearch / 2019年11月25日 / ※当調査レポートでは、多嚢胞性卵巣症候群治療の世界市場について調査・分析し、多嚢胞性卵巣症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬）、用途別（病院薬局、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多嚢胞性卵巣症候群治療市場動向 ・主要企業別マーケットシェア ・多嚢胞性卵巣症候群治療の種類別市場規模2014-2019 （経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬） ・多嚢胞性卵巣症候群治療の用途別市場規模2014-2019 （病院薬局、ドラッグストア） ・多嚢胞性卵巣症候群治療の北米市場：主要企業・種類別/用途別市場規模 ・多嚢胞性卵巣症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Polycystic Ovary Syndrome Treatment means treatment of  a common hormonal endocrine disorder that affects women of child bearing age (15 to 49 years). This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female body.In 2018, the global Polycystic Ovary Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Polycystic Ovary Syndrome Treatment status, future forecast, growth opportunity, key market and...
  • 女性医療用医薬品の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100772 / GlobalInfoResearch / 2019年9月5日 / 本調査レポートは、女性医療用医薬品の世界市場について調べ、まとめました。種類別セグメントは、閉経後骨粗鬆症治療薬、不妊治療薬、子宮内膜症治療薬、避妊薬、閉経治療薬、多嚢胞性卵巣症候群治療薬、その他等、用途別セグメントは、リトルガールズ、若い女性、高齢者の女性等に区分しました。女性医療用医薬品の世界市場概観、メーカー動向、メーカー別女性医療用医薬品シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・女性医療用医薬品の市場概観 ・女性医療用医薬品の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・女性医療用医薬品の企業別販売動向、市場シェア、市場集中度、競争動向 ・女性医療用医薬品の世界市場規模 ・女性医療用医薬品の北米市場分析（アメリカ、カナダ、メキシコ等） ・女性医療用医薬品のアメリカ市場規模推移 ・女性医療用医薬品のカナダ市場規模推移 ・女性医療用医薬品のメキシコ市場規模推移 ・女性医療用医薬品のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Women's health drug is the health drug specifically for women. Scope of the Report: The worldwide market for Women's Health Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Women's Health Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report...

    • ◆H&Iグローバルリサーチのお客様（例）◆